AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Robin Healthcare, Inc. is a technology company specializing in healthcare software aimed at alleviating administrative burdens for medical professionals. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company offers a range of solutions including a smart assistant device, clinical documentation tools, order and medication entry, chart reviews, billing and coding, and referral management services. Its innovative electronic medical recording technology utilizes machine learning, artificial intelligence, and voice recognition to seamlessly capture patient notes and facilitate care coordination through natural dialogue between doctors and patients. This approach not only enhances compliance and billing accuracy but also allows healthcare providers to concentrate more on patient care rather than administrative tasks.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.
Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Hello Heart Inc. is a health technology company that offers a comprehensive application designed to help individuals manage their blood pressure effectively. Founded in 2013 and based in Redwood City, California, the company provides users with a wireless blood pressure monitor paired with a smartphone application that delivers real-time, personalized health tips. The application is particularly aimed at individuals with high blood pressure, empowering them to understand and improve their heart health. By facilitating self-management and promoting behavior change, Hello Heart seeks to prevent serious health risks associated with hypertension, which is a major cost factor for employers. The program is clinically based, ensuring that users receive reliable guidance in an engaging manner.
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.
Rightway Healthcare, Inc. operates a healthcare advocacy platform that focuses on optimizing healthcare expenditure for employers and employees. Founded in 2017 and based in New York, the company provides a consumer portal that offers diagnosis education, treatment path navigation, and patient advocacy services. Its platform combines patient navigation with analytics to guide users toward optimal care and therapies, while also simplifying access through an employee application that allows for on-demand navigation. Additionally, Rightway integrates pharmacy benefit management (PBM) solutions into its services, ensuring prescriptions are directed to the lowest net cost. This approach aligns incentives and involves clinicians in the care journey, ultimately aiming to reduce costs and improve health outcomes for its users.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Earli is focused on transforming cancer detection and treatment by developing innovative technologies that enable early identification of tumors. The company specializes in creating synthetic biopsies, which are designed to induce cancer cells to produce non-human synthetic biomarkers. These biomarkers can be detected in biological samples such as blood, urine, or breath, allowing for the visualization of tumors that are typically too small to identify in traditional screenings. By leveraging these programmable genetic constructs, Earli aims to provide real-time data on cancer presence and progression, facilitating personalized treatment approaches and improving the chances of successful intervention. Overall, Earli's mission is to make the experience of cancer more manageable by ensuring timely detection and response.
Curai is a virtual care company that leverages artificial intelligence to provide chat-based primary care services at reduced costs. Founded in 2017 by Neal Khosla and Xavier Amatriain, the company is headquartered in Palo Alto and aims to make high-quality, affordable primary care accessible globally. Curai's platform combines the expertise of clinicians with advanced AI technologies, facilitating a learning healthcare system that enhances the efficiency and effectiveness of care delivery. By helping patients communicate relevant information to medical professionals, Curai enables more accurate diagnoses and fosters improved patient outcomes. The service is available to individuals directly or through partnerships with enterprises.
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
SiPhox Inc. is a company based in Cambridge, Massachusetts, specializing in the design and manufacture of disposable testing kits for COVID-19 and other diseases. Founded in 2020, SiPhox offers a handheld testing device that utilizes advanced technology to perform RNA, DNA, and protein testing. The company's testing kits incorporate multiplexing of RNA, antibody, and antigen tests on a single silicon photonic chip, enhanced by plasmon resonance and silicon photonic resonator readout. This innovative approach allows users to safely conduct tests for various diseases in both point-of-care and at-home settings, using disposable SiPhox Biosensor cartridges and the SiPhox PROBE.
Caption Health, Inc. develops artificial intelligence-based software solutions designed to assist healthcare providers in acquiring and interpreting ultrasound exams. The company's flagship product, Caption AI, offers real-time guidance for performing echocardiography, enabling practitioners to capture diagnostic-quality images, automate quality assessments, and interpret ultrasound results effectively. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company focuses on enhancing the capabilities of ultrasound technology through innovative software, ultimately aiming to improve patient outcomes in medical imaging.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Using AI to control the scanner minimizes the need for breath-holds, making MRI exams available for a broader base of patients and conditions.
Yes Health Inc. is a California-based company that specializes in mobile health solutions, focusing on diabetes prevention and management. Founded in 2015, it offers a comprehensive application that provides personalized nutrition and fitness advice, as well as support from health coaches. The program is designed to engage users actively, making it accessible and effective for individuals looking to adopt healthier lifestyles and prevent the onset of diabetes. Yes Health's team comprises physicians, health coaches, and engineers who work together to create a program that is both affordable and easy to follow. In addition to prevention, the application also aids individuals already diagnosed with diabetes in managing their symptoms effectively, with the overarching mission of promoting lasting health habits and reducing the impact of diabetes.
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread.
The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Karius, Inc. is a life sciences company dedicated to generating genomic insights for infectious diseases. It offers the Karius Test, a non-invasive blood test that utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. Karius also provides laboratory services for pathogen biomarker detection tailored for biopharmaceutical companies. Founded in 2014, the company is based in Redwood City, California, with an additional office in Menlo Park. Its laboratory holds CLIA certification and CAP accreditation, allowing it to conduct high-complexity clinical laboratory testing to support rapid clinical decision-making.
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Digi-Prex operates a monthly medication delivery platform that focuses on serving patients with chronic diseases in India. Founded in 2019 and headquartered in Hyderabad, with an additional office in San Francisco, the company enables patients to upload prescriptions and receive their medications at discounted rates from local pharmacies. In addition to medication delivery, Digi-Prex offers a comprehensive management solution tailored to individual health needs, providing a one-stop platform for chronic disease management. This approach aims to simplify access to necessary treatments while supporting patients in effectively managing their health conditions.
Hello Heart Inc. is a health technology company that offers a comprehensive application designed to help individuals manage their blood pressure effectively. Founded in 2013 and based in Redwood City, California, the company provides users with a wireless blood pressure monitor paired with a smartphone application that delivers real-time, personalized health tips. The application is particularly aimed at individuals with high blood pressure, empowering them to understand and improve their heart health. By facilitating self-management and promoting behavior change, Hello Heart seeks to prevent serious health risks associated with hypertension, which is a major cost factor for employers. The program is clinically based, ensuring that users receive reliable guidance in an engaging manner.
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.
CureSkin is a Bengaluru-based company that specializes in AI-powered dermatological care through a mobile application. Founded in 2016, the app utilizes computer vision technology to analyze photographs of users' skin, identifying issues such as acne, dark spots, scars, and pigmentation. Based on this analysis, CureSkin offers personalized treatment plans, skincare regimens, and recommendations for products and dermatologists. The platform aims to bridge the gap for individuals lacking access to trained dermatological professionals, providing tailored solutions for skin health and hair fall management.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.
Curai is a virtual care company that leverages artificial intelligence to provide chat-based primary care services at reduced costs. Founded in 2017 by Neal Khosla and Xavier Amatriain, the company is headquartered in Palo Alto and aims to make high-quality, affordable primary care accessible globally. Curai's platform combines the expertise of clinicians with advanced AI technologies, facilitating a learning healthcare system that enhances the efficiency and effectiveness of care delivery. By helping patients communicate relevant information to medical professionals, Curai enables more accurate diagnoses and fosters improved patient outcomes. The service is available to individuals directly or through partnerships with enterprises.
Curai is a virtual care company that leverages artificial intelligence to provide chat-based primary care services at reduced costs. Founded in 2017 by Neal Khosla and Xavier Amatriain, the company is headquartered in Palo Alto and aims to make high-quality, affordable primary care accessible globally. Curai's platform combines the expertise of clinicians with advanced AI technologies, facilitating a learning healthcare system that enhances the efficiency and effectiveness of care delivery. By helping patients communicate relevant information to medical professionals, Curai enables more accurate diagnoses and fosters improved patient outcomes. The service is available to individuals directly or through partnerships with enterprises.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Clara Health is a medical technology company that offers a software platform designed to facilitate patient participation in clinical trials. The platform simplifies the clinical trial process by assisting patients in navigating through various options, allowing them to filter and connect with relevant trials tailored to their needs. Additionally, Clara's technology supports crucial aspects of clinical trial management, including protocol design, site selection, and monitoring patient adherence. By placing the patient at the center of the process, Clara Health aims to enhance accessibility and engagement in clinical research.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.
DiscernDx is a healthcare company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to personalized clinical and molecular data, enabling proactive health management. By leveraging artificial intelligence and machine learning, DiscernDx's platform detects, measures, and interprets signals from the body, facilitating early disease detection and personalized care. This approach empowers individuals to make informed health decisions, ultimately aiming to improve lives and transform healthcare practices.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.
DocTalk Solutions India Private Limited develops and offers a mobile application that enables patients to communicate with their doctors. The company's application enables users to chat with their doctor, save medical reports, and get prescriptions. DocTalk Solutions India Private Limited was founded in 2016 and is based in Mumbai, India.
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool.
The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more.
Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.
Provider of on demand drug delivery platform intended to create a better experience for patients at a lower price. Nimble partners with pharmacies nationwide to provide prescription delivery, as well as a mobile app for patients to manage and review prescriptions/orders from their phone.
Karius, Inc. is a life sciences company dedicated to generating genomic insights for infectious diseases. It offers the Karius Test, a non-invasive blood test that utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. Karius also provides laboratory services for pathogen biomarker detection tailored for biopharmaceutical companies. Founded in 2014, the company is based in Redwood City, California, with an additional office in Menlo Park. Its laboratory holds CLIA certification and CAP accreditation, allowing it to conduct high-complexity clinical laboratory testing to support rapid clinical decision-making.
MDAlgorithms uses smart algorithms, computer vision, and AI to provide real time mobile tools for people with health disorders. The company's mission is to disrupt the old physician centric medical system and put the patient in the center.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool.
The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more.
Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.
Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.
DocTalk Solutions India Private Limited develops and offers a mobile application that enables patients to communicate with their doctors. The company's application enables users to chat with their doctor, save medical reports, and get prescriptions. DocTalk Solutions India Private Limited was founded in 2016 and is based in Mumbai, India.
MDacne mission is to disrupt the old physician-centric medical system and put the patient in the center. Using smart algorithms and computer vision to provide real-time mobile tools for people with health disorders. The company's first mobile app, MDacne, targets 500 million people suffering from Acne and provides them an immediate self-diagnosis personalized treatment plan in order to treat their Acne and enhance their quality of life.
Syllable is a developer of a text and voice-based platform designed to enhance communication between healthcare providers and patients. By leveraging artificial intelligence, the platform facilitates interactions regarding primary care, specialty referrals, vaccinations, and general practice information. This technology enables patients to access healthcare information and guidance beyond traditional clinical settings, improving overall communication and patient engagement in their healthcare journeys.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Medisas, Inc. offers a cloud-based service that facilitates the transfer of medical information among healthcare professionals during shift changes. Based in the United States, the company develops record-keeping software aimed at improving patient care and safety. This software allows clinicians to document and share critical information related to shift changes, patient transfers, and discharges across various devices. By streamlining communication among healthcare providers, Medisas enhances organizational efficiency and supports better patient outcomes throughout the care process. The team comprises experienced clinicians, engineers, and designers dedicated to transforming hospital software to meet the evolving needs of healthcare organizations.
PatientBank offers an online platform that facilitates the requesting, storage, and sharing of medical records. This service enables patients to gather their medical information from various healthcare providers, including doctors and hospitals, and share it with family members or other care providers as needed. By streamlining the process of accessing and managing medical records, PatientBank aims to enhance the communication between patients and healthcare professionals, ultimately supporting better health management and checkups.
Caption Health, Inc. develops artificial intelligence-based software solutions designed to assist healthcare providers in acquiring and interpreting ultrasound exams. The company's flagship product, Caption AI, offers real-time guidance for performing echocardiography, enabling practitioners to capture diagnostic-quality images, automate quality assessments, and interpret ultrasound results effectively. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company focuses on enhancing the capabilities of ultrasound technology through innovative software, ultimately aiming to improve patient outcomes in medical imaging.
Vida Health is a virtual care platform designed from the ground up to treat multiple chronic health conditions simultaneously, through a balance of machine learning that personalizes each person’s treatment and a human connection with real life health coaches and therapists who bring the empathy and accountability people need to reach their goals.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.
Luminostics, Inc. is a healthcare technology company based in Houston, Texas, established in 2015. The company has developed a smartphone-based adaptor that enables users to conduct molecular-level health assessments through do-it-yourself disease testing. This innovative solution allows healthcare professionals and consumers to obtain health information quickly, with tests that can be completed in just 15 minutes. By combining mobile technology with accessible testing methods, Luminostics aims to enhance the way individuals monitor and manage their health.
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.
Luminist, Inc. is a Newark, California-based company that focuses on developing a diagnostic platform for the early detection of liver disease. Founded in 2015, Luminist aims to provide a rapidly scalable and low-cost solution for screening various diseases, including liver conditions and cancer, through a data-driven approach. The company's technology transforms biochemical data into crucial health information, allowing patients to receive insights from a single test. Luminist operates as a subsidiary of DiscernDx.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool.
The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more.
Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.
Provider of on demand drug delivery platform intended to create a better experience for patients at a lower price. Nimble partners with pharmacies nationwide to provide prescription delivery, as well as a mobile app for patients to manage and review prescriptions/orders from their phone.
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.
Editas Medicine is a clinical-stage company focused on developing innovative genome editing therapeutics to address serious diseases at the genetic level. Established in 2013 and headquartered in Cambridge, Massachusetts, with an additional site in Boulder, Colorado, the company leverages its proprietary CRISPR/Cas9 technology to create precise and corrective molecular modifications. This approach utilizes a protein-RNA complex, which includes the Cas9 enzyme and a guide RNA, to target and repair specific DNA sequences. Editas Medicine aims to translate its advances in genome editing into transformative human therapies, supported by a robust portfolio of patents and intellectual property that underpins its foundational technologies.
Klarismo Limited offers 3D Body Scan, a product that provides volumetric measurements of muscle tissues and fat deposits in human body. It allows users to acquire a 3D model of their body using magnetic resonance imaging to measure and track their health and fitness potential. The company makes MRI scans and helps private medical imaging centers optimize the utilization of their assets; and builds database of full body MRI scans and makes it available for medical research. The company serves health conscious consumers and amateur athletes. Klarismo Limited was incorporated in 2014 and is based in London, United Kingdom.
Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Caption Health, Inc. develops artificial intelligence-based software solutions designed to assist healthcare providers in acquiring and interpreting ultrasound exams. The company's flagship product, Caption AI, offers real-time guidance for performing echocardiography, enabling practitioners to capture diagnostic-quality images, automate quality assessments, and interpret ultrasound results effectively. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company focuses on enhancing the capabilities of ultrasound technology through innovative software, ultimately aiming to improve patient outcomes in medical imaging.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Vida Health is a virtual care platform designed from the ground up to treat multiple chronic health conditions simultaneously, through a balance of machine learning that personalizes each person’s treatment and a human connection with real life health coaches and therapists who bring the empathy and accountability people need to reach their goals.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Kyron, Inc. is a company based in Palo Alto, California, that specializes in analyzing medical records from routine care to produce valuable medical insights. Founded in 2013, Kyron focuses on identifying latent associations between various medical conditions, interventions, and outcomes, thereby generating practice-based evidence that can inform healthcare practices and improve patient care.
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.